Mutant KRAS is a druggable target for pancreatic cancerProceedings of the National Academy of SciencesDecember 2, 201310.1073/pnas.1314307110Cited by 290SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis